» Articles » PMID: 34572687

Comparative Effectiveness Study of Home-Based Interventions to Prevent CA-MRSA Infection Recurrence

Abstract

Recurrent skin and soft tissue infections (SSTI) caused by Community-Associated Methicillin-Resistant (CA-MRSA) or Methicillin-Sensitive (CA-MSSA) present treatment challenges. This community-based trial examined the effectiveness of an evidence-based intervention (CDC Guidelines, topical decolonization, surface decontamination) to reduce SSTI recurrence, mitigate household contamination/transmission, and improve patient-reported outcomes. Participants (n = 186) were individuals with confirmed MRSA(+)/MSSA(+) SSTIs and their household members. During home visits; Community Health Workers/Promotoras provided hygiene instructions; a five-day supply of nasal mupirocin; chlorhexidine for body cleansing; and household disinfecting wipes (Experimental; EXP) or Usual Care Control (UC CON) pamphlets. Primary outcome was six-month SSTI recurrence from electronic health records (EHR). Home visits (months 0; 3) and telephone assessments (months 0; 1; 6) collected self-report data. Index patients and participating household members provided surveillance culture swabs. Secondary outcomes included household surface contamination; household member colonization and transmission; quality of life; and satisfaction with care. There were no significant differences in SSTI recurrence between EXP and UC in the intent-to-treat cohort (n = 186) or the enrolled cohort (n = 119). EXP participants showed reduced but non-significant colonization rates. EXP and UC did not differ in household member transmission, contaminated surfaces, or patient-reported outcomes. This intervention did not reduce clinician-reported MRSA/MSSA SSTI recurrence. Taken together with other recent studies that employed more intensive decolonization protocols, it is possible that a promotora-delivered intervention instructing treatment for a longer or repetitive duration may be effective and should be examined by future studies.

Citing Articles

Molecular Epidemiologic and Geo-Spatial Characterization of Cultured from Skin and Soft Tissue Infections from United States-Born and Immigrant Patients Living in New York City.

Cheng Immergluck L, Lin X, Geng R, Edelson M, Ali F, Li C Antibiotics (Basel). 2023; 12(10).

PMID: 37887242 PMC: 10604313. DOI: 10.3390/antibiotics12101541.


Stakeholder Engagement In a Comparative Effectiveness/Implementation Study to Prevent Infection Recurrence: CA-MRSA Project (CAMP2).

DOrazio B, Ramachandran J, Khalida C, Gonzalez J, Kost R, Vasquez K Prog Community Health Partnersh. 2022; 16(1):45-60.

PMID: 35342110 PMC: 9930995. DOI: 10.1353/cpr.2022.0005.

References
1.
Eells S, David M, Taylor A, Ortiz N, Kumar N, Sieth J . Persistent environmental contamination with USA300 methicillin-resistant Staphylococcus aureus and other pathogenic strain types in households with S. aureus skin infections. Infect Control Hosp Epidemiol. 2014; 35(11):1373-82. DOI: 10.1086/678414. View

2.
Knox J, Uhlemann A, Miller M, Hafer C, Vasquez G, Vavagiakis P . Environmental contamination as a risk factor for intra-household Staphylococcus aureus transmission. PLoS One. 2012; 7(11):e49900. PMC: 3496667. DOI: 10.1371/journal.pone.0049900. View

3.
Daum R, Miller L, Immergluck L, Fritz S, Creech C, Young D . A Placebo-Controlled Trial of Antibiotics for Smaller Skin Abscesses. N Engl J Med. 2017; 376(26):2545-2555. PMC: 6886470. DOI: 10.1056/NEJMoa1607033. View

4.
Uhlemann A, Knox J, Miller M, Hafer C, Vasquez G, Ryan M . The environment as an unrecognized reservoir for community-associated methicillin resistant Staphylococcus aureus USA300: a case-control study. PLoS One. 2011; 6(7):e22407. PMC: 3144231. DOI: 10.1371/journal.pone.0022407. View

5.
Creech C, Al-Zubeidi D, Fritz S . Prevention of Recurrent Staphylococcal Skin Infections. Infect Dis Clin North Am. 2015; 29(3):429-64. PMC: 4552962. DOI: 10.1016/j.idc.2015.05.007. View